Diversified Healthcare Trust (DHC)
- Previous Close
2.2900 - Open
2.2400 - Bid 1.9300 x 100
- Ask 2.5700 x 100
- Day's Range
2.2200 - 2.2900 - 52 Week Range
2.0000 - 4.2400 - Volume
609,834 - Avg. Volume
932,536 - Market Cap (intraday)
545.193M - Beta (5Y Monthly) 2.01
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5500 - Earnings Date May 5, 2025
- Forward Dividend & Yield 0.04 (1.78%)
- Ex-Dividend Date Apr 22, 2025
- 1y Target Est
3.25
Diversified Healthcare Trust is a real estate investment trust, or REIT, organized under Maryland law, which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of December 31, 2024, we owned 367 properties located in 36 states and Washington, D.C. As of December 31, 2024, our owned properties include: 98 medical office and life science properties with approximately 8.0 million rentable square feet; 259 senior living communities, including independent living (including active adult), assisted living, memory care and skilled nursing facilities, or SNFs, with approximately 27,000 living units; and 10 wellness centers with approximately 812,000 square feet of interior space plus outdoor developed facilities. As of December 31, 2024, we also owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet.
www.dhcreit.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DHC
View MorePerformance Overview: DHC
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DHC
View MoreValuation Measures
Market Cap
552.43M
Enterprise Value
3.32B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.36
Price/Book (mrq)
0.28
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
22.29
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.76%
Return on Assets (ttm)
-0.65%
Return on Equity (ttm)
-17.24%
Revenue (ttm)
1.5B
Net Income Avi to Common (ttm)
-370.26M
Diluted EPS (ttm)
-1.5500
Balance Sheet and Cash Flow
Total Cash (mrq)
144.58M
Total Debt/Equity (mrq)
149.65%
Levered Free Cash Flow (ttm)
-150.97M